Corcept Therapeutics
(NASDAQ:CORT)
$24.18
0.95[4.09%]
At close: Mar 18
$24.18
0[0.00%]
After Hours: 4:30PM EDT

GET A REPORT ON CORT SENT RIGHT TO YOUR INBOX

Corcept Therapeutics Stock (NASDAQ:CORT), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Buy
Highest Price Target1
$42.00
Lowest Price Target1
$22.00
Consensus Price Target1
$30.63

Analyst Rating Summary1

Analyst Ratings
Oct 23
0
0
0
0
0
Nov 23
2
Dec 23
1
Jan
1
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Truist Securities
HC Wainwright & Co.
Canaccord Genuity
Piper Sandler
SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Corcept Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/16/2024CORTBuy Now
Corcept Therapeutics
$24.1873.7%Truist Securities
Joon Lee
$36 → $42MaintainsBuyGet Alert
01/02/2024CORTBuy Now
Corcept Therapeutics
$24.1815.8%HC Wainwright & Co.
Swayampakula Ramakanth
$34 → $28MaintainsBuyGet Alert
12/13/2023CORTBuy Now
Corcept Therapeutics
$24.1857.15%Canaccord Genuity
Edward Nash
$37 → $38MaintainsBuyGet Alert
11/06/2023CORTBuy Now
Corcept Therapeutics
$24.1857.15%Truist Securities
Joon Lee
$29 → $38UpgradeHold → BuyGet Alert
11/02/2023CORTBuy Now
Corcept Therapeutics
$24.1840.61%HC Wainwright & Co.
Swayampakula Ramakanth
$32 → $34MaintainsBuyGet Alert
10/02/2023CORTBuy Now
Corcept Therapeutics
$24.1819.93%Truist Securities
Joon Lee
→ $29ReiteratesHold → HoldGet Alert
08/25/2023CORTBuy Now
Corcept Therapeutics
$24.1844.75%Canaccord Genuity
Edward Nash
$34 → $35MaintainsBuyGet Alert
08/03/2023CORTBuy Now
Corcept Therapeutics
$24.1828.21%Piper Sandler
David Amsellem
$27 → $31MaintainsOverweightGet Alert
08/03/2023CORTBuy Now
Corcept Therapeutics
$24.1819.93%Truist Securities
Gregory Fraser
$26 → $29MaintainsHoldGet Alert
08/03/2023CORTBuy Now
Corcept Therapeutics
$24.1832.34%HC Wainwright & Co.
Swayampakula Ramakanth
$30 → $32MaintainsBuyGet Alert
05/26/2023CORTBuy Now
Corcept Therapeutics
$24.187.53%Truist Securities
Gregory Fraser
$28 → $26MaintainsHoldGet Alert
05/04/2023CORTBuy Now
Corcept Therapeutics
$24.1824.07%HC Wainwright & Co.
Swayampakula Ramakanth
$30 → $30Reiterates → BuyGet Alert
04/11/2023CORTBuy Now
Corcept Therapeutics
$24.183.39%SVB Leerink
Roanna Ruiz
→ $25Initiates → Market PerformGet Alert
04/04/2023CORTBuy Now
Corcept Therapeutics
$24.1811.66%Piper Sandler
David Amsellem
→ $27Initiates → OverweightGet Alert
03/08/2023CORTBuy Now
Corcept Therapeutics
$24.1832.34%Canaccord Genuity
Edward Nash
$33 → $32MaintainsBuyGet Alert
03/01/2023CORTBuy Now
Corcept Therapeutics
$24.1824.07%HC Wainwright & Co.
Swayampakula Ramakanth
→ $30Reiterates → BuyGet Alert
02/15/2023CORTBuy Now
Corcept Therapeutics
$24.18-9.02%Jefferies
Dennis Ding
$35 → $22DowngradeBuy → HoldGet Alert
12/09/2022CORTBuy Now
Corcept Therapeutics
$24.1824.07%HC Wainwright & Co.
Swayampakula Ramakanth
$33 → $30MaintainsBuyGet Alert
11/08/2022CORTBuy Now
Corcept Therapeutics
$24.1815.8%Truist Securities
Gregory Fraser
$30 → $28MaintainsHoldGet Alert

FAQ

Q

What is the target price for Corcept Therapeutics (CORT)?

A

The latest price target for Corcept Therapeutics (NASDAQ: CORT) was reported by Truist Securities on February 16, 2024. The analyst firm set a price target for $42.00 expecting CORT to rise to within 12 months (a possible 73.70% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Corcept Therapeutics (CORT)?

A

The latest analyst rating for Corcept Therapeutics (NASDAQ: CORT) was provided by Truist Securities, and Corcept Therapeutics maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Corcept Therapeutics (CORT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Corcept Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Corcept Therapeutics was filed on February 16, 2024 so you should expect the next rating to be made available sometime around February 16, 2025.

Q

Is the Analyst Rating Corcept Therapeutics (CORT) correct?

A

While ratings are subjective and will change, the latest Corcept Therapeutics (CORT) rating was a maintained with a price target of $36.00 to $42.00. The current price Corcept Therapeutics (CORT) is trading at is $24.18, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch